{
  "directed": true,
  "multigraph": true,
  "graph": {
    "pybel_version": "0.13.1",
    "document_metadata": {
      "name": "A role for APP in Wnt signalling links synapse loss with β-amyloid production.",
      "version": "1.0.0",
      "description": "This knowledge assembly is specific to Alzheimer's Disease for the AETIONOMY project. It encodes the pathological mechanisms in neurons in the human brain as well as additional evidence from mice and rats. This model includes different pathways such as apoptosis signaling, calcium signaling, cholesterol homeostasis, endocytosis, GSK activation, inflammatory responses, oxidative stress of mitochondria and endoplasmic reticulum, etc. In this version, we have added additional mechanisms/pathways to describe the functional consequences of SNPs linked with genes implicated in Alzheimer's Disease through GWAS.",
      "copyright": "Copyright © 2012-2018 Fraunhofer Institute SCAI, All rights reserved",
      "authors": "Esther Wollert",
      "licenses": "Private Ownership to Fraunhofer Institute SCAI",
      "contact": "charles.hoyt@scai.fraunhofer.de"
    },
    "namespace_url": {
      "MESH": "https://raw.githubusercontent.com/pharmacome/terminology/1b20f0637c395f8aa89c2e2e342d7b704062c242/external/mesh-names.belns",
      "CHEBI": "https://raw.githubusercontent.com/pharmacome/terminology/1b20f0637c395f8aa89c2e2e342d7b704062c242/external/chebi-names.belns",
      "HGNC": "https://raw.githubusercontent.com/pharmacome/terminology/1b20f0637c395f8aa89c2e2e342d7b704062c242/external/hgnc-symbols.belns",
      "GO": "https://raw.githubusercontent.com/pharmacome/terminology/1b20f0637c395f8aa89c2e2e342d7b704062c242/external/go-names.belns",
      "HBP": "https://raw.githubusercontent.com/pharmacome/terminology/785431732a26d6809b4162d98b95687d16404e63/export/hbp.belns"
    },
    "namespace_pattern": {
      "dbSNP": "rs[0-9]+",
      "TAXONOMY": "^\\d+$"
    },
    "namespaces_uncached": [],
    "annotation_url": {
      "Anatomy": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/anatomy/anatomy-20170511.belanno",
      "CellLine": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/cell-line/cell-line-20170511.belanno",
      "CellStructure": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/cell-structure/cell-structure-20170511.belanno",
      "Cell": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/cell/cell-20170511.belanno",
      "Confidence": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/confidence/confidence-1.0.0.belanno",
      "Disease": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/disease/disease-20170511.belanno",
      "Gender": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/gender/gender-1.0.0.belanno",
      "MeSHAnatomy": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/mesh-anatomy/mesh-anatomy-20170511.belanno",
      "MeSHDisease": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/mesh-diseases/mesh-diseases-20170511.belanno",
      "Subgraph": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/neurommsig/neurommsig-1.0.3.belanno",
      "TextLocation": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/text-location/text-location-1.0.1.belanno"
    },
    "annotation_pattern": {
      "Species": "^\\d+$"
    },
    "annotation_list": {},
    "path": "/Users/cthoyt/dev/hbp-knowledge/hbp_knowledge/elliott2018.bel"
  },
  "nodes": [
    {
      "function": "Abundance",
      "namespace": "CHEBI",
      "name": "amyloid-beta polypeptide 40",
      "id": "2ca2eb795438fe9e0f24c1e9d332717de5e344ddfee00ce8df89c5b901d85db5994d6ffd383e40a90bde264f33e75b220476b3de86c89f0658bf281c872f0bb6"
    },
    {
      "function": "Abundance",
      "namespace": "CHEBI",
      "name": "amyloid-beta",
      "id": "a9487b29439483c6840095610dd3e496e3ca9cccc3a8d71e0385a39b570f3c0a26965ac06d83265e1c08deaae7998272d4f4c21ec0534f8be3fd8e4e57dbb3a2"
    },
    {
      "function": "Abundance",
      "namespace": "CHEBI",
      "name": "fasudil hydrochloride",
      "id": "912d467aabd48eabe9977eafa4da82f252879d7cf659393ea528cc2e7c712c97d751b7cbe41e00024c57d6f265f62a575cd52d2ae0cee5bd97d5d3fe083c7310"
    },
    {
      "function": "Abundance",
      "namespace": "MESH",
      "name": "Dendritic Spines",
      "id": "9f5512cad4083a1d70bd15dfad45bd5889a3d7cc7d4a7b20effbf451a5db30df56867272bc3f9925642c92b2142969d33d0ea0f1e90dc59c2281e2178154651a"
    },
    {
      "function": "BiologicalProcess",
      "namespace": "GO",
      "name": "Wnt signaling pathway, planar cell polarity pathway",
      "id": "1c96d1a264fac28d192c002a2e764f501656f77f87a6857815640bf5400c48c8e61ef55aa174acb217b74790c85ac11b42fd193a1c2516692f253bb5a30c4f56"
    },
    {
      "function": "BiologicalProcess",
      "namespace": "GO",
      "name": "amyloid-beta formation",
      "id": "78b3edf87ac63c62c4027270412a8d18bf9cded8d1db6354615c4b7e79930f50560150fde88c2996f8bafaefe2809ece6b1f9300ff1e79f0aad756ba51d9a65e"
    },
    {
      "function": "BiologicalProcess",
      "namespace": "GO",
      "name": "canonical Wnt signaling pathway",
      "id": "50f09b91bf0bb0e2c43d7b8ef3cadc927b420000bd29bdbef19e78d6929ffd17d1a5ec498d3e3eea24dec20e82a74080fa91ed102a7c5f94946ae91e6e4ecec7"
    },
    {
      "function": "BiologicalProcess",
      "namespace": "GO",
      "name": "non-canonical Wnt signaling pathway",
      "id": "be4305c859a5b1b4787088d39bd1aa750bc5eb57e872757b0ff6f01168dc81d59921a457e219a1ee6356b0c344270ef67bb538c12a74f7fe1e8ff75788682c75"
    },
    {
      "function": "BiologicalProcess",
      "namespace": "HBP",
      "name": "HBP00061",
      "id": "4684805cb6a923e042bc0d7786901c6df4c3026e8d5989b8db6c4319d015ff7aa4eb9bd7a851276191f401eb2f7a19a35c41d3ddf08f43e663edf5ae6a870e82"
    },
    {
      "function": "Complex",
      "members": [
        {
          "function": "Protein",
          "namespace": "HGNC",
          "name": "APP",
          "id": "ed1d45f3255226e4210017e6c179950e0e04a300727326d7fea6a9659868e8818ff64fd5e8a2a92a703fb1566b3f48323750ac6c28e7adb40843053d276710bc"
        },
        {
          "function": "Protein",
          "namespace": "HGNC",
          "name": "LRP6",
          "id": "be5ece32839c7b6b770b934cfcbe97dda329d09d734637d98c8b07c39f0439cd937cbba3c2a4b9b969de9eea5081237fea475ed8de4123f03b8db7536a408686"
        }
      ],
      "id": "6df6edd7ad8c818792e90db8e144a4203e9314f9248f3b69190b96e29653a5b34b67351ae68263673a7572ccd46e0557ea921ed1777b88ff160414f0650246b9"
    },
    {
      "function": "Complex",
      "members": [
        {
          "function": "Protein",
          "namespace": "HGNC",
          "name": "APP",
          "id": "ed1d45f3255226e4210017e6c179950e0e04a300727326d7fea6a9659868e8818ff64fd5e8a2a92a703fb1566b3f48323750ac6c28e7adb40843053d276710bc"
        },
        {
          "function": "Protein",
          "namespace": "HGNC",
          "name": "VANGL2",
          "id": "89fbda5575e54fa3baefd8e5f04e1b08bc6c96fea1d66af162f646660d14feb1bfe7c9a6ce3fb54f0764bfa4e3334c9e354526901153c5d1b54a64f616e2fc58"
        }
      ],
      "id": "44d126124ef75afe9000be371ac7571e730c17b23e938449986c5daa12bccb67b83a8f59c5abef137d2cbef424f01cae572267386e39a8ea4d122ba3bcc79bf4"
    },
    {
      "function": "Composite",
      "members": [
        {
          "function": "Abundance",
          "namespace": "CHEBI",
          "name": "fasudil hydrochloride",
          "id": "912d467aabd48eabe9977eafa4da82f252879d7cf659393ea528cc2e7c712c97d751b7cbe41e00024c57d6f265f62a575cd52d2ae0cee5bd97d5d3fe083c7310"
        },
        {
          "function": "Protein",
          "namespace": "HGNC",
          "name": "DKK1",
          "id": "43353c695c37d05100ccc4d88cfc994417614c34fe111df6314c9f4143abc3ea6c90a9bf584c4c8e811efaaa5fc268e61dbdc6ca23c67cba998a28632f6400b7"
        }
      ],
      "id": "08035500fce6c67e9ce63f9ef3f8f9e4d69aa496fa6d1b77092d92f956015d260497f910b942a78ca77ed1c4bb332eb4b191a9175ea12e1b54714cb205c1dc4b"
    },
    {
      "function": "Composite",
      "members": [
        {
          "function": "Protein",
          "namespace": "HGNC",
          "name": "APP",
          "id": "ed1d45f3255226e4210017e6c179950e0e04a300727326d7fea6a9659868e8818ff64fd5e8a2a92a703fb1566b3f48323750ac6c28e7adb40843053d276710bc"
        },
        {
          "function": "Protein",
          "namespace": "HGNC",
          "name": "DKK1",
          "id": "43353c695c37d05100ccc4d88cfc994417614c34fe111df6314c9f4143abc3ea6c90a9bf584c4c8e811efaaa5fc268e61dbdc6ca23c67cba998a28632f6400b7"
        }
      ],
      "id": "d7b20f0c3ade644852e9b12103f484cea14a382afff80ed0c00f47be69431e4d4979e62ab6eda650da5b79a9156d7b34b9d2c4d6b0451e88b573f8bc9815ee17"
    },
    {
      "function": "Composite",
      "members": [
        {
          "function": "Protein",
          "namespace": "HGNC",
          "name": "APP",
          "id": "ed1d45f3255226e4210017e6c179950e0e04a300727326d7fea6a9659868e8818ff64fd5e8a2a92a703fb1566b3f48323750ac6c28e7adb40843053d276710bc"
        },
        {
          "function": "Protein",
          "namespace": "HGNC",
          "name": "LRP6",
          "id": "be5ece32839c7b6b770b934cfcbe97dda329d09d734637d98c8b07c39f0439cd937cbba3c2a4b9b969de9eea5081237fea475ed8de4123f03b8db7536a408686"
        }
      ],
      "id": "67b089c59c4ce8e7b7728150cbb1cee2a44c8bcede23cfdfc006acec8fda8727a02562ebf61cc2a50dd922db166546a5e2038fd4129874516f1b4d5b88c165d6"
    },
    {
      "function": "Composite",
      "members": [
        {
          "function": "Protein",
          "namespace": "HGNC",
          "name": "APP",
          "id": "ed1d45f3255226e4210017e6c179950e0e04a300727326d7fea6a9659868e8818ff64fd5e8a2a92a703fb1566b3f48323750ac6c28e7adb40843053d276710bc"
        },
        {
          "function": "Protein",
          "namespace": "HGNC",
          "name": "VANGL2",
          "id": "89fbda5575e54fa3baefd8e5f04e1b08bc6c96fea1d66af162f646660d14feb1bfe7c9a6ce3fb54f0764bfa4e3334c9e354526901153c5d1b54a64f616e2fc58"
        }
      ],
      "id": "f1c02b3b86e31f6ede6589eb481881686d1b3ebfda64683219221ba8d6d5b34d8cf239a2f4f47388090d895a311ed7120583fdff75482b785b6115f229303dea"
    },
    {
      "function": "Protein",
      "namespace": "HGNC",
      "name": "APP",
      "id": "ed1d45f3255226e4210017e6c179950e0e04a300727326d7fea6a9659868e8818ff64fd5e8a2a92a703fb1566b3f48323750ac6c28e7adb40843053d276710bc"
    },
    {
      "function": "Protein",
      "namespace": "HGNC",
      "name": "APP",
      "variants": [
        {
          "kind": "hgvs",
          "identifier": "p.Lys670Asn"
        },
        {
          "kind": "hgvs",
          "identifier": "p.Met671Leu"
        }
      ],
      "id": "dd017074fe4ff9074e5f4e2a5329b30e7cd14858402f43f6ce267f0cc0e20c269da0a8294ab6a707d68c350f47cf0e37d4a35b83c82b648130641e54f7bcae84"
    },
    {
      "function": "Protein",
      "namespace": "HGNC",
      "name": "DKK1",
      "id": "43353c695c37d05100ccc4d88cfc994417614c34fe111df6314c9f4143abc3ea6c90a9bf584c4c8e811efaaa5fc268e61dbdc6ca23c67cba998a28632f6400b7"
    },
    {
      "function": "Protein",
      "namespace": "HGNC",
      "name": "LRP6",
      "id": "be5ece32839c7b6b770b934cfcbe97dda329d09d734637d98c8b07c39f0439cd937cbba3c2a4b9b969de9eea5081237fea475ed8de4123f03b8db7536a408686"
    },
    {
      "function": "Protein",
      "namespace": "HGNC",
      "name": "VANGL2",
      "id": "89fbda5575e54fa3baefd8e5f04e1b08bc6c96fea1d66af162f646660d14feb1bfe7c9a6ce3fb54f0764bfa4e3334c9e354526901153c5d1b54a64f616e2fc58"
    },
    {
      "function": "Protein",
      "namespace": "HGNC",
      "name": "WNT3A",
      "id": "975931064dd3793b95edb24719e7af84fd454d85179f0483c44870b07c538713f15214adca8a3c51a53796a789114a7d1e5bf7acebb463c884f0920673f92b17"
    },
    {
      "function": "Protein",
      "namespace": "HGNC",
      "name": "WNT5A",
      "id": "89d1f4005f576b0c7f0ddff2d1cd32e74c1d2a300a676019d18d39268db893f37c67ea630d9471d6ed6b20b7fb543956a733be2b8d25a838ca8bce862dbaa25c"
    }
  ],
  "links": [
    {
      "line": 64,
      "relation": "increases",
      "evidence": "APP did though potentiate both Wnt3a-driven Wnt-β-catenin signalling and Wnt5a-driven Wnt-PCP signalling. ",
      "citation": {
        "type": "PubMed",
        "name": "Transl Psychiatry. 2018 Sep 20;8(1):179. doi: 10.1038/s41398-018-0231-6.",
        "reference": "30232325"
      },
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "object": {
        "modifier": "Activity"
      },
      "source": 15,
      "target": 20,
      "key": "40f10310dde91c5b6f88aad6e5c923bee3f283f80aaee98b6fef416e33178a4f9df84deff2bee07ad9412a94a55bbe4f48efcff6596fa91c9bbcbde8ebbb53a9"
    },
    {
      "line": 66,
      "relation": "increases",
      "evidence": "APP did though potentiate both Wnt3a-driven Wnt-β-catenin signalling and Wnt5a-driven Wnt-PCP signalling. ",
      "citation": {
        "type": "PubMed",
        "name": "Transl Psychiatry. 2018 Sep 20;8(1):179. doi: 10.1038/s41398-018-0231-6.",
        "reference": "30232325"
      },
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "object": {
        "modifier": "Activity"
      },
      "source": 15,
      "target": 21,
      "key": "f60f2d521a7514da99fdafc2577b31593fc15ad4f178d4d4459a0eb323e0f214287ca41a68a32aabf08a588c39c5efb2f3ccf8567914e8ebb536b3f8ec4cc7c1"
    },
    {
      "line": 94,
      "relation": "increases",
      "evidence": "In contrast with wild-type APP which, as before, potentiated both canonical and non-canonical Wnt signalling, the Swedish mutant form of APP antagonised canonical Wnt signalling (Fig. 2a), and potentiated non-canonical Wnt signalling to a greater degree than wild-type APP (APPWT) (Fig. 2b).",
      "citation": {
        "type": "PubMed",
        "name": "Transl Psychiatry. 2018 Sep 20;8(1):179. doi: 10.1038/s41398-018-0231-6.",
        "reference": "30232325"
      },
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "source": 15,
      "target": 6,
      "key": "364f6cf69790d377b9bb073bfe9c7c94b8b2d4100f9f31cb4cac6fb10ff736eb5e332dc978388a2657deb2f0650f8121399087df2ebd21c76b029723e4a53d14"
    },
    {
      "line": 95,
      "relation": "increases",
      "evidence": "In contrast with wild-type APP which, as before, potentiated both canonical and non-canonical Wnt signalling, the Swedish mutant form of APP antagonised canonical Wnt signalling (Fig. 2a), and potentiated non-canonical Wnt signalling to a greater degree than wild-type APP (APPWT) (Fig. 2b).",
      "citation": {
        "type": "PubMed",
        "name": "Transl Psychiatry. 2018 Sep 20;8(1):179. doi: 10.1038/s41398-018-0231-6.",
        "reference": "30232325"
      },
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "source": 15,
      "target": 7,
      "key": "b6cee5f4135fd90528ce40ff2484e418817f250d6113e3bd98ebe0cb77b566f5befcf609a212efe654ff1c2f4d301252623ea6e460e40888faa6242a43746aa9"
    },
    {
      "relation": "hasVariant",
      "source": 15,
      "target": 16,
      "key": "b85314f5a5461211499a416be07ef12e291a036d686fdb3ffc200546b934c2d488cfea9b20207d605b9a1b7b8bf296a589500377bec39dadac47dc3a764cbf72"
    },
    {
      "line": 128,
      "relation": "increases",
      "evidence": " Overexpression of APP enhanced the inhibitory effects of Dkk1 on Wnt3a induced Wnt-β-catenin signalling, counteracting the enhanced activity resulting from APP overexpression and reducing the IC50 of Dkk1 to 122ng/mL from 173ng/mL in the absence of APP (Fig. 2f) .",
      "citation": {
        "type": "PubMed",
        "name": "Transl Psychiatry. 2018 Sep 20;8(1):179. doi: 10.1038/s41398-018-0231-6.",
        "reference": "30232325"
      },
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "object": {
        "modifier": "Activity"
      },
      "source": 15,
      "target": 17,
      "key": "5fe7d86b8679bce37e5eaa2567deda172ccbc6c4ef1c1251da6df719974b095628a2cde0a488d34d996101e0e87cc72a5497d6b5c56927695c9f48c255318a05"
    },
    {
      "line": 136,
      "relation": "increases",
      "evidence": "In contrast, the stimulatory effects of Dkk1 on WntPCP signalling induced by Wnt5a were enhanced by APP overexpression, decreasing the EC50 of Dkk1 to 599ng/ mL from 1405ng/mL (Fig. 2g). ",
      "citation": {
        "type": "PubMed",
        "name": "Transl Psychiatry. 2018 Sep 20;8(1):179. doi: 10.1038/s41398-018-0231-6.",
        "reference": "30232325"
      },
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "object": {
        "modifier": "Activity"
      },
      "source": 15,
      "target": 17,
      "key": "b81d1e0f2d5c586c6cfa76ff0cf4c131ad670fa60fa92837bf8af4c42883b2ce3a14e0be173c6fa120099560ad85ffcc53e013159e94f0d6c142e10e1b837b5a"
    },
    {
      "line": 143,
      "relation": "increases",
      "evidence": "Aβ synaptoxicity is Dkk1-dependent12,24 and also appears to be APP-dependent25.",
      "citation": {
        "type": "PubMed",
        "name": "Transl Psychiatry. 2018 Sep 20;8(1):179. doi: 10.1038/s41398-018-0231-6.",
        "reference": "30232325"
      },
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "source": 15,
      "target": 8,
      "key": "2cbc7920c60cd9f5626058367d8c61f3b8377696cb0a568988eeb0530dc273b0bdc0a4af3e3869d06d5ed9797b0820c66c411252e0975c02c6e9ea1265443543"
    },
    {
      "line": 65,
      "relation": "increases",
      "evidence": "APP did though potentiate both Wnt3a-driven Wnt-β-catenin signalling and Wnt5a-driven Wnt-PCP signalling. ",
      "citation": {
        "type": "PubMed",
        "name": "Transl Psychiatry. 2018 Sep 20;8(1):179. doi: 10.1038/s41398-018-0231-6.",
        "reference": "30232325"
      },
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "subject": {
        "modifier": "Activity"
      },
      "source": 20,
      "target": 6,
      "key": "3c383401cd2a9da081cad070af84e00d19a1842a3e935005b1a9b3ce4cebf4ed2c0b4d57fb33571c08b44df8829e18b85432dbe5fb8c750940bdf8096a681e1b"
    },
    {
      "line": 131,
      "relation": "increases",
      "evidence": " Overexpression of APP enhanced the inhibitory effects of Dkk1 on Wnt3a induced Wnt-β-catenin signalling, counteracting the enhanced activity resulting from APP overexpression and reducing the IC50 of Dkk1 to 122ng/mL from 173ng/mL in the absence of APP (Fig. 2f) .",
      "citation": {
        "type": "PubMed",
        "name": "Transl Psychiatry. 2018 Sep 20;8(1):179. doi: 10.1038/s41398-018-0231-6.",
        "reference": "30232325"
      },
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "subject": {
        "modifier": "Activity"
      },
      "source": 20,
      "target": 6,
      "key": "9a3062884ed6c6c0ef136f0254085ecab71158a8f544b5a7d7e7e8a93b128019aec8092865c0e5ecffb6d41bcbf670646991b7bee30c0e4ed918c47147a9419f"
    },
    {
      "line": 108,
      "relation": "decreases",
      "evidence": "In cells expressing either wild-type or Swedish APP, the amount of Aβ produced was reduced in cells stimulated with Wnt3a, which promotes Wnt-βcatenin signalling, whereas Aβ production was enhanced in cells stimulated with Wnt5a, which promotes Wnt-PCP signalling (Fig. 2c).",
      "citation": {
        "type": "PubMed",
        "name": "Transl Psychiatry. 2018 Sep 20;8(1):179. doi: 10.1038/s41398-018-0231-6.",
        "reference": "30232325"
      },
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "subject": {
        "modifier": "Activity"
      },
      "source": 20,
      "target": 1,
      "key": "6364a73a2d621edc0f6d3c896b347bafbfed8f9cb6acaa55edf890cd87661ad54043375923ccd272b76d10f7e429e71d3b5cf1668536db912a1d21549ccb5eba"
    },
    {
      "line": 110,
      "relation": "increases",
      "evidence": "In cells expressing either wild-type or Swedish APP, the amount of Aβ produced was reduced in cells stimulated with Wnt3a, which promotes Wnt-βcatenin signalling, whereas Aβ production was enhanced in cells stimulated with Wnt5a, which promotes Wnt-PCP signalling (Fig. 2c).",
      "citation": {
        "type": "PubMed",
        "name": "Transl Psychiatry. 2018 Sep 20;8(1):179. doi: 10.1038/s41398-018-0231-6.",
        "reference": "30232325"
      },
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "subject": {
        "modifier": "Activity"
      },
      "source": 20,
      "target": 1,
      "key": "603ccdf6dd3f0672b6de6dfb0af84456bfcec9239c144a9b38920bf82d86caa6d4a8b7d5df9084c381cb1a0e834bbca3fd5346fd8518e1b57ea66f1925fffb87"
    },
    {
      "line": 75,
      "relation": "association",
      "evidence": "APP has previously been shown to interact with Vangl2, a Wnt-PCP-speciﬁc co-receptor protein, and independently has been shown to bind LRP6, a receptor component of the Wnt-β-catenin pathway21.",
      "citation": {
        "type": "PubMed",
        "name": "Transl Psychiatry. 2018 Sep 20;8(1):179. doi: 10.1038/s41398-018-0231-6.",
        "reference": "30232325"
      },
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "source": 6,
      "target": 18,
      "key": "832e2121121ca7c9ffd9418b42581b2ba37868cfd83e884a8e20eb7baedbd06f824db99bb477278ecc760e0aaa964fe845af85148decc9eeeed3ce94aef0a7b4"
    },
    {
      "line": 109,
      "relation": "decreases",
      "evidence": "In cells expressing either wild-type or Swedish APP, the amount of Aβ produced was reduced in cells stimulated with Wnt3a, which promotes Wnt-βcatenin signalling, whereas Aβ production was enhanced in cells stimulated with Wnt5a, which promotes Wnt-PCP signalling (Fig. 2c).",
      "citation": {
        "type": "PubMed",
        "name": "Transl Psychiatry. 2018 Sep 20;8(1):179. doi: 10.1038/s41398-018-0231-6.",
        "reference": "30232325"
      },
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "source": 6,
      "target": 1,
      "key": "0ee877ee6d939ae62713140b57bfe6bdf878b544360d658020c30cd8723be1e67137a012c5dfb834580222332fe9bfc0f09b3911bc330c0007878d673d945cba"
    },
    {
      "line": 122,
      "relation": "negativeCorrelation",
      "evidence": "Comparison of signalling activity and Aβ production under each of the different conditions showed clearly that Aβ production was negatively correlated with Wnt-β-catenin signalling activity (Fig. 2d) and positively correlated with Wnt-PCP signalling (Fig. 2e).",
      "citation": {
        "type": "PubMed",
        "name": "Transl Psychiatry. 2018 Sep 20;8(1):179. doi: 10.1038/s41398-018-0231-6.",
        "reference": "30232325"
      },
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "source": 6,
      "target": 5,
      "key": "fe662db002c507584921c1e79dabfb7959bebecd261815bc0b6df143a53bde6bfa1bb74e483f57ad65312a79ecc0bfecfc619f1b4407e6189ee428d3a6b61d69"
    },
    {
      "line": 67,
      "relation": "increases",
      "evidence": "APP did though potentiate both Wnt3a-driven Wnt-β-catenin signalling and Wnt5a-driven Wnt-PCP signalling. ",
      "citation": {
        "type": "PubMed",
        "name": "Transl Psychiatry. 2018 Sep 20;8(1):179. doi: 10.1038/s41398-018-0231-6.",
        "reference": "30232325"
      },
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "subject": {
        "modifier": "Activity"
      },
      "source": 21,
      "target": 4,
      "key": "195ad14128ed38d165917833d45aef9ff72dcc77244fe2041b8e3667b4df10233ba000f0b5dfa2f3841b1e52f7d04d3c2ae3dd0e481e66d01ac36402b0e92586"
    },
    {
      "line": 73,
      "relation": "association",
      "evidence": "APP has previously been shown to interact with Vangl2, a Wnt-PCP-speciﬁc co-receptor protein, and independently has been shown to bind LRP6, a receptor component of the Wnt-β-catenin pathway21.",
      "citation": {
        "type": "PubMed",
        "name": "Transl Psychiatry. 2018 Sep 20;8(1):179. doi: 10.1038/s41398-018-0231-6.",
        "reference": "30232325"
      },
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "source": 4,
      "target": 19,
      "key": "154f662bdd2a180f449fe31d1ebc6bb773b8e975042b8ba1026be8129a973a4706033ab312116ac817ec3aa19249a8515f6b68bc1bcc89e164d75654260f0eef"
    },
    {
      "line": 111,
      "relation": "increases",
      "evidence": "In cells expressing either wild-type or Swedish APP, the amount of Aβ produced was reduced in cells stimulated with Wnt3a, which promotes Wnt-βcatenin signalling, whereas Aβ production was enhanced in cells stimulated with Wnt5a, which promotes Wnt-PCP signalling (Fig. 2c).",
      "citation": {
        "type": "PubMed",
        "name": "Transl Psychiatry. 2018 Sep 20;8(1):179. doi: 10.1038/s41398-018-0231-6.",
        "reference": "30232325"
      },
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "source": 4,
      "target": 1,
      "key": "cde8861d6465f3de1bda4edd94741912b4e9cf38ea84888375c0aeaf6abebe4865e9ab9372f5b235eaaad7e3513718aa993a7a5c5e4f37774b5773f27159f792"
    },
    {
      "line": 123,
      "relation": "positiveCorrelation",
      "evidence": "Comparison of signalling activity and Aβ production under each of the different conditions showed clearly that Aβ production was negatively correlated with Wnt-β-catenin signalling activity (Fig. 2d) and positively correlated with Wnt-PCP signalling (Fig. 2e).",
      "citation": {
        "type": "PubMed",
        "name": "Transl Psychiatry. 2018 Sep 20;8(1):179. doi: 10.1038/s41398-018-0231-6.",
        "reference": "30232325"
      },
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "source": 4,
      "target": 5,
      "key": "876c9511c06068e1b2cae435ff0cd11d977a50467bd04facabd7f23210348571d235ceb8b8b9141c1b686f1755ed029e3891eb745b95adc96c129d2ef88289e1"
    },
    {
      "relation": "hasComponent",
      "source": 10,
      "target": 15,
      "key": "86f9c16142b62459dec3fdb1121fdece06ab2cb3ff76b25d714b07311508252b81f3edb17be1868a6ea7316350009de9fcdd9b7593dd17b20d7dbef32677285d"
    },
    {
      "relation": "hasComponent",
      "source": 10,
      "target": 19,
      "key": "1a3c42ed4eb50e26be81a6e9df66e44426630328d1c836255a9430cc17524c78513039cb4191fe86aecf10b7f63ec23f3828665ed872da35fcf2c6cde9536b13"
    },
    {
      "line": 73,
      "relation": "association",
      "evidence": "APP has previously been shown to interact with Vangl2, a Wnt-PCP-speciﬁc co-receptor protein, and independently has been shown to bind LRP6, a receptor component of the Wnt-β-catenin pathway21.",
      "citation": {
        "type": "PubMed",
        "name": "Transl Psychiatry. 2018 Sep 20;8(1):179. doi: 10.1038/s41398-018-0231-6.",
        "reference": "30232325"
      },
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "source": 19,
      "target": 4,
      "key": "f69dfb9e2227feef43fd2f64c3542482d87901d03212c75e3697fcc0cca401bcf91804a6f648ca5b573e93c7ed4e421339b5b2d26b413bea959b268c82051dca"
    },
    {
      "relation": "hasComponent",
      "source": 9,
      "target": 15,
      "key": "fd15b8aa6afee254726b1617ac7c0e048fd41d461fda204c73e3faea12fc70751cdedc7eca0cba8f136da7c71e8d73d6114e7bf4a80a689aa3a4f7ffc6c8a1dc"
    },
    {
      "relation": "hasComponent",
      "source": 9,
      "target": 18,
      "key": "2ddfe2417d90beb42f8c04e7536a37e78f2770e714cf45c81d3a5e352b2d4e83e8f9d9198fc87ea683a3cfa04306377bc1eb0affbd786218b84954151f962781"
    },
    {
      "line": 75,
      "relation": "association",
      "evidence": "APP has previously been shown to interact with Vangl2, a Wnt-PCP-speciﬁc co-receptor protein, and independently has been shown to bind LRP6, a receptor component of the Wnt-β-catenin pathway21.",
      "citation": {
        "type": "PubMed",
        "name": "Transl Psychiatry. 2018 Sep 20;8(1):179. doi: 10.1038/s41398-018-0231-6.",
        "reference": "30232325"
      },
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "source": 18,
      "target": 6,
      "key": "da8020fda7d1a4b092324f80154ae21f26e430220e9c92747dd210bc59dab69d4af58443cd9ff7d4c44e2f8474a73eb58a93d84056ad7989dc496822bd70a63b"
    },
    {
      "relation": "hasComponent",
      "source": 13,
      "target": 15,
      "key": "2b5e3c15b60db47ecf3d5c4b8361ad1218223a42dcf131257954fb77dd67a4aec3881d8d6f94b8ad1c2333dc514541f59057748ecf8df3f58f8cf83b452e5664"
    },
    {
      "relation": "hasComponent",
      "source": 13,
      "target": 18,
      "key": "27d0ec6880336c067341fc6e5cc56df9edeb1bb29971f0430f728876edeb8c6cced38cab9486f6819caf96fb372507fe96f05e67750aeba284662535750e7793"
    },
    {
      "line": 81,
      "relation": "increases",
      "evidence": " The ability of APP to potentiate Wnt-β-catenin signalling in response to Wnt3a was enhanced by the overexpression of LRP6, and attenuated by Vangl2 (Fig. 1g).",
      "citation": {
        "type": "PubMed",
        "name": "Transl Psychiatry. 2018 Sep 20;8(1):179. doi: 10.1038/s41398-018-0231-6.",
        "reference": "30232325"
      },
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "source": 13,
      "target": 6,
      "key": "056a45ee3ed09a6ac09ed1bfb8297aacbb49f30befcefc4e3aa4fdf16be643ad2fc39a2e1274a9ef665424417b896d776f578f0d8a62b6cebfabf4575defa2e0"
    },
    {
      "line": 88,
      "relation": "decreases",
      "evidence": " Conversely, the ability of APP to potentiate Wnt-PCP signalling in response to Wnt5a was enhanced by Vangl2 and attenuated by LRP6 (Fig. 1h). ",
      "citation": {
        "type": "PubMed",
        "name": "Transl Psychiatry. 2018 Sep 20;8(1):179. doi: 10.1038/s41398-018-0231-6.",
        "reference": "30232325"
      },
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "source": 13,
      "target": 4,
      "key": "595d7b3076958116b0bd9c89370159beed7cb6c4eab305a506304937eaf670a3cb46d239aa8b7cca47fc613d79697b720c9b4cd3c6d0fa26bea464093384a90b"
    },
    {
      "line": 115,
      "relation": "decreases",
      "evidence": "Co-expression of LRP6 with APP reduced the production of Aβ, while co-expression of Vangl2 with APP led to increased Aβ production (Fig. 2c).",
      "citation": {
        "type": "PubMed",
        "name": "Transl Psychiatry. 2018 Sep 20;8(1):179. doi: 10.1038/s41398-018-0231-6.",
        "reference": "30232325"
      },
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "source": 13,
      "target": 1,
      "key": "687815e0db8ec63f10b701d05044f77dd57b80c6237c7e60343a2f35079ebef2657e22a11f8b893aa6a571d43314b45bd37615926ffe20fb7c568d11a2447cec"
    },
    {
      "relation": "hasComponent",
      "source": 14,
      "target": 15,
      "key": "d27d4ecdb2b76bd00b0527b7a59633979adf74f855dc0c19ed11a726bfc4603e6e418075e27b322563046b3ea9ccf0b2496c4c67a14ce366f946a85a46af04be"
    },
    {
      "relation": "hasComponent",
      "source": 14,
      "target": 19,
      "key": "ea6e5ea73207b229eeb7874eb620b87a4855c8024978a308425c8caffa36dfb7f47b2d4c58486ac8acbe96248657026929fbd6957b4927f1e9a52ad4347549a6"
    },
    {
      "line": 82,
      "relation": "decreases",
      "evidence": " The ability of APP to potentiate Wnt-β-catenin signalling in response to Wnt3a was enhanced by the overexpression of LRP6, and attenuated by Vangl2 (Fig. 1g).",
      "citation": {
        "type": "PubMed",
        "name": "Transl Psychiatry. 2018 Sep 20;8(1):179. doi: 10.1038/s41398-018-0231-6.",
        "reference": "30232325"
      },
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "source": 14,
      "target": 6,
      "key": "ae0316e6ceffbab60af073773b36ee8b26c42cf60e53044ed29f510a199dac90209fa9588588c122603027bd5fd7fa9e71a3330cacc3407a6b6f5707dfe0c822"
    },
    {
      "line": 87,
      "relation": "increases",
      "evidence": " Conversely, the ability of APP to potentiate Wnt-PCP signalling in response to Wnt5a was enhanced by Vangl2 and attenuated by LRP6 (Fig. 1h). ",
      "citation": {
        "type": "PubMed",
        "name": "Transl Psychiatry. 2018 Sep 20;8(1):179. doi: 10.1038/s41398-018-0231-6.",
        "reference": "30232325"
      },
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "source": 14,
      "target": 4,
      "key": "9ae7f167ee61c90b082cc2898bbf5221f24392cc7fb3d983e2374d1858e9695fc1fadce08c4746833652ff0a5c72cca26360153c0c529af20a9b225c6c54564f"
    },
    {
      "line": 116,
      "relation": "increases",
      "evidence": "Co-expression of LRP6 with APP reduced the production of Aβ, while co-expression of Vangl2 with APP led to increased Aβ production (Fig. 2c).",
      "citation": {
        "type": "PubMed",
        "name": "Transl Psychiatry. 2018 Sep 20;8(1):179. doi: 10.1038/s41398-018-0231-6.",
        "reference": "30232325"
      },
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "source": 14,
      "target": 1,
      "key": "18ff7887d81cef1ff91568120550e7ff6049abd664ee395864cbac3616565a3b03da6a92c01dc003fdbe753b3bfc07c3faafc5dd344f6d24cf2a433a8639b801"
    },
    {
      "line": 97,
      "relation": "decreases",
      "evidence": "In contrast with wild-type APP which, as before, potentiated both canonical and non-canonical Wnt signalling, the Swedish mutant form of APP antagonised canonical Wnt signalling (Fig. 2a), and potentiated non-canonical Wnt signalling to a greater degree than wild-type APP (APPWT) (Fig. 2b).",
      "citation": {
        "type": "PubMed",
        "name": "Transl Psychiatry. 2018 Sep 20;8(1):179. doi: 10.1038/s41398-018-0231-6.",
        "reference": "30232325"
      },
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "source": 16,
      "target": 6,
      "key": "6bf007cfa977d5de2a4d3c5da5e2f961330a1754204ae5a9b2c967c5e6b0e4513380c61025fba0e71e06972f51a0145e4292bd121789939d1cfbb87400bd21ef"
    },
    {
      "line": 98,
      "relation": "increases",
      "evidence": "In contrast with wild-type APP which, as before, potentiated both canonical and non-canonical Wnt signalling, the Swedish mutant form of APP antagonised canonical Wnt signalling (Fig. 2a), and potentiated non-canonical Wnt signalling to a greater degree than wild-type APP (APPWT) (Fig. 2b).",
      "citation": {
        "type": "PubMed",
        "name": "Transl Psychiatry. 2018 Sep 20;8(1):179. doi: 10.1038/s41398-018-0231-6.",
        "reference": "30232325"
      },
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "source": 16,
      "target": 7,
      "key": "d9d7cc4befa5a8f94645ad8122e2efdf57c0688990bb0827597b31688863843105b2eda720af89347fa3bf272da1016f23aaee34c09fcdfe20631e588d6f9390"
    },
    {
      "line": 102,
      "relation": "increases",
      "evidence": "As expected, cells expressing the Swedish mutant form of APP695 produced much more Aβ than the control wildtype-expressing cells.",
      "citation": {
        "type": "PubMed",
        "name": "Transl Psychiatry. 2018 Sep 20;8(1):179. doi: 10.1038/s41398-018-0231-6.",
        "reference": "30232325"
      },
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "source": 16,
      "target": 1,
      "key": "8d02a9dd239c58a169a4a007b144f173a5829e90fddbf270defd48db1d6e868b4992b5961bab6bf62c93fd49147dcb6d5fdd731e7965c65dad7b27aa445b6cb9"
    },
    {
      "line": 142,
      "relation": "increases",
      "evidence": "Aβ synaptoxicity is Dkk1-dependent12,24 and also appears to be APP-dependent25.",
      "citation": {
        "type": "PubMed",
        "name": "Transl Psychiatry. 2018 Sep 20;8(1):179. doi: 10.1038/s41398-018-0231-6.",
        "reference": "30232325"
      },
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "source": 1,
      "target": 8,
      "key": "534b4abb60ac00d1de5fc4a51440064428685177606d0b2f7951ce9cacb0ac50e32fef8695d99a5fc96cf2e5fe5d47f4f4711d632fe36e35ea8f83a66fd2f13e"
    },
    {
      "line": 122,
      "relation": "negativeCorrelation",
      "evidence": "Comparison of signalling activity and Aβ production under each of the different conditions showed clearly that Aβ production was negatively correlated with Wnt-β-catenin signalling activity (Fig. 2d) and positively correlated with Wnt-PCP signalling (Fig. 2e).",
      "citation": {
        "type": "PubMed",
        "name": "Transl Psychiatry. 2018 Sep 20;8(1):179. doi: 10.1038/s41398-018-0231-6.",
        "reference": "30232325"
      },
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "source": 5,
      "target": 6,
      "key": "9985665d4407a593252824ad5e292928fab99c1bd3f3f0320ab47f7921707a6d9a976245800e308cb9c7ea1168792f27709db77dd9babb07e708fc900c8c3cca"
    },
    {
      "line": 123,
      "relation": "positiveCorrelation",
      "evidence": "Comparison of signalling activity and Aβ production under each of the different conditions showed clearly that Aβ production was negatively correlated with Wnt-β-catenin signalling activity (Fig. 2d) and positively correlated with Wnt-PCP signalling (Fig. 2e).",
      "citation": {
        "type": "PubMed",
        "name": "Transl Psychiatry. 2018 Sep 20;8(1):179. doi: 10.1038/s41398-018-0231-6.",
        "reference": "30232325"
      },
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "source": 5,
      "target": 4,
      "key": "31ddac74ed826ff8f20bae38431be8559b60e85c7d4d774043e0a5a1228b1c8dea8fdf5a308faa1029fdad3338c75b2b915f4160df0404708cbd340c1e19f28c"
    },
    {
      "line": 129,
      "relation": "decreases",
      "evidence": " Overexpression of APP enhanced the inhibitory effects of Dkk1 on Wnt3a induced Wnt-β-catenin signalling, counteracting the enhanced activity resulting from APP overexpression and reducing the IC50 of Dkk1 to 122ng/mL from 173ng/mL in the absence of APP (Fig. 2f) .",
      "citation": {
        "type": "PubMed",
        "name": "Transl Psychiatry. 2018 Sep 20;8(1):179. doi: 10.1038/s41398-018-0231-6.",
        "reference": "30232325"
      },
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "subject": {
        "modifier": "Activity"
      },
      "object": {
        "modifier": "Activity"
      },
      "source": 17,
      "target": 20,
      "key": "3fb3547e1caa4a2e5c49fb60f10272cf7d2e9bf3abfe7ca4393e5dfada4d70285752f725da8ed947dce5c802723c7d526c811fda169d091fded5bad7e0cd8723"
    },
    {
      "line": 130,
      "relation": "decreases",
      "evidence": " Overexpression of APP enhanced the inhibitory effects of Dkk1 on Wnt3a induced Wnt-β-catenin signalling, counteracting the enhanced activity resulting from APP overexpression and reducing the IC50 of Dkk1 to 122ng/mL from 173ng/mL in the absence of APP (Fig. 2f) .",
      "citation": {
        "type": "PubMed",
        "name": "Transl Psychiatry. 2018 Sep 20;8(1):179. doi: 10.1038/s41398-018-0231-6.",
        "reference": "30232325"
      },
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "subject": {
        "modifier": "Activity"
      },
      "source": 17,
      "target": 6,
      "key": "40c3432ccac8cc94f28caa01054633e2053cc07354b78159719b5e0751b0d7371288a78032a968f9f8727ea5d3f658d785d9fffbee40b896bbf6242501d576ea"
    },
    {
      "line": 137,
      "relation": "increases",
      "evidence": "In contrast, the stimulatory effects of Dkk1 on WntPCP signalling induced by Wnt5a were enhanced by APP overexpression, decreasing the EC50 of Dkk1 to 599ng/ mL from 1405ng/mL (Fig. 2g). ",
      "citation": {
        "type": "PubMed",
        "name": "Transl Psychiatry. 2018 Sep 20;8(1):179. doi: 10.1038/s41398-018-0231-6.",
        "reference": "30232325"
      },
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "subject": {
        "modifier": "Activity"
      },
      "object": {
        "modifier": "Activity"
      },
      "source": 17,
      "target": 21,
      "key": "54cbace45b2fe0cdf7cb6a488ca9b3e2414b4ef0551d0cecc69aaa751ce6c41ee003ed650d2ee538a247af3496badda2cacefc37346819661df14aeddc28aad2"
    },
    {
      "line": 138,
      "relation": "increases",
      "evidence": "In contrast, the stimulatory effects of Dkk1 on WntPCP signalling induced by Wnt5a were enhanced by APP overexpression, decreasing the EC50 of Dkk1 to 599ng/ mL from 1405ng/mL (Fig. 2g). ",
      "citation": {
        "type": "PubMed",
        "name": "Transl Psychiatry. 2018 Sep 20;8(1):179. doi: 10.1038/s41398-018-0231-6.",
        "reference": "30232325"
      },
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "subject": {
        "modifier": "Activity"
      },
      "source": 17,
      "target": 4,
      "key": "41f2338f5c46bb25ceefd2aa1b83d2a7fb5869d7f2d45d26b8f7875d00859e845689067b5f4055dd0023494ff44e0e64a482c1151df5fc18daac0efb17af144f"
    },
    {
      "line": 144,
      "relation": "increases",
      "evidence": "Aβ synaptoxicity is Dkk1-dependent12,24 and also appears to be APP-dependent25.",
      "citation": {
        "type": "PubMed",
        "name": "Transl Psychiatry. 2018 Sep 20;8(1):179. doi: 10.1038/s41398-018-0231-6.",
        "reference": "30232325"
      },
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "source": 17,
      "target": 8,
      "key": "fead031d45c130fdc04507851741b9cd3bba4f2ebf5d817eecc24fddcac2f3560fc4dfc2063c0e117ed9e7cc305daebb55d9afe1ba19b32ede719cec2080e978"
    },
    {
      "line": 163,
      "relation": "decreases",
      "evidence": "Dkk1 resulted in substantial loss of dendritic spines, which was blocked by 10µM fasudil treatment (Fig. 3e, f).",
      "citation": {
        "type": "PubMed",
        "name": "Transl Psychiatry. 2018 Sep 20;8(1):179. doi: 10.1038/s41398-018-0231-6.",
        "reference": "30232325"
      },
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "source": 17,
      "target": 3,
      "key": "1cec3f4b769304acdfbb969761cc7034db1281f4e4d1e55a50980c3c22badc59da41cd3f7a86dec6d55b7e317e4ee76857fdb822279be644149007f26cf9b4c0"
    },
    {
      "line": 170,
      "relation": "decreases",
      "evidence": "In addition to causing a signiﬁcant reduction in the numbers of dendritic spines, Dkk1 treatment also resulted a substantial increase in levels of all three Aβ species (Fig. 3g).",
      "citation": {
        "type": "PubMed",
        "name": "Transl Psychiatry. 2018 Sep 20;8(1):179. doi: 10.1038/s41398-018-0231-6.",
        "reference": "30232325"
      },
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "source": 17,
      "target": 3,
      "key": "4891bbc00dc1b94b4fc9b364516ef51c6cd5653ad1d0a4d4efe234d0650348b53fee44f0b5179938091ef9be1db360ca6a85bdb7706c71556eeb5c429a3cdbd4"
    },
    {
      "line": 169,
      "relation": "increases",
      "evidence": "In addition to causing a signiﬁcant reduction in the numbers of dendritic spines, Dkk1 treatment also resulted a substantial increase in levels of all three Aβ species (Fig. 3g).",
      "citation": {
        "type": "PubMed",
        "name": "Transl Psychiatry. 2018 Sep 20;8(1):179. doi: 10.1038/s41398-018-0231-6.",
        "reference": "30232325"
      },
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "source": 17,
      "target": 1,
      "key": "c77c4b501768f8681aaf5e8e8f79ccfe9ee42881991891a0abfc3fe076e97441f480fbfdc4562d23b13053503fab2da20c79a9def9bbc8e1f9572877bdacc9df"
    },
    {
      "line": 176,
      "relation": "increases",
      "evidence": "Notably, in parallel with the protective effect of fasudil on synapses (Fig. 3e, f), treatment with fasudil reversed the stimulatory effects of Dkk1 on Aβ production (Fig. 3g).",
      "citation": {
        "type": "PubMed",
        "name": "Transl Psychiatry. 2018 Sep 20;8(1):179. doi: 10.1038/s41398-018-0231-6.",
        "reference": "30232325"
      },
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "source": 17,
      "target": 5,
      "key": "0e274a90bf1b7a35670268d55b47728775ea3f8aef4e439c9542baad97370ec1ef75667d0aa38963cca287532c3d2591b0707725d598d371a43e45b749ba5e66"
    },
    {
      "relation": "hasComponent",
      "source": 12,
      "target": 15,
      "key": "a7838e70e4f52ddaa5b68055859ec3654cd37368c3eb3467cf7342d4dd1748785cf2dd38ca0827d4054f38c5cc89647180f6b3647c199fc6f892b2c1f2ab8e68"
    },
    {
      "relation": "hasComponent",
      "source": 12,
      "target": 17,
      "key": "1a68a9e7a38f81fc99704e79fa4caf0a96bb714ddfb10823401697bb7c906ee6cc1585958b08cba8f82687e4449d261db654e9776b99ddce5011cc656b62bc3f"
    },
    {
      "line": 149,
      "relation": "decreases",
      "evidence": "As previously reported, Dkk1-treatment markedly reduced the number of dendritic spines on APP+/+ neurons (Fig. 3a, b). In contrast, APP-deﬁciency protected neurons against the synaptotoxic activity of Dkk1 (Fig. 3a, b).",
      "citation": {
        "type": "PubMed",
        "name": "Transl Psychiatry. 2018 Sep 20;8(1):179. doi: 10.1038/s41398-018-0231-6.",
        "reference": "30232325"
      },
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "source": 12,
      "target": 3,
      "key": "79e96d8a53fb13849cf56dc9bfca85483505d44c98fb5404fc16143f9e1d9a0d5726accc9583f30fd8c920c52792788a3c3335b0c0fed4e6f61127a69a9509a8"
    },
    {
      "line": 154,
      "relation": "decreases",
      "evidence": "The Wnt-PCP signalling pathway acts through RhoA and ROCK26, and can be inhibited pharmacologically, for example, with fasudil24, a ROCK inhibitor that is in clinical use for the treatment of cerebral vasospasm.",
      "citation": {
        "type": "PubMed",
        "name": "Transl Psychiatry. 2018 Sep 20;8(1):179. doi: 10.1038/s41398-018-0231-6.",
        "reference": "30232325"
      },
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "source": 2,
      "target": 4,
      "key": "ed9f7f076fc926dc15503a66db9a98bc99d36a607d775ae40e857dcfe5bb1758e694ef0095f089842a251cbf81a9b926228a2cdaccc60693a59935c8a45c54dc"
    },
    {
      "line": 159,
      "relation": "decreases",
      "evidence": "Fasudil also reversed the stimulatory effect of Vangl2 and Dkk1 on Aβ production in the same cells as determined by ELISA based quantiﬁcation of Aβ1–40 levels in the paired culture media from the same experiments (Fig. 3d). ",
      "citation": {
        "type": "PubMed",
        "name": "Transl Psychiatry. 2018 Sep 20;8(1):179. doi: 10.1038/s41398-018-0231-6.",
        "reference": "30232325"
      },
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "source": 2,
      "target": 0,
      "key": "8451737a54f1c11c9200112f9397d3fdd117a8e3d8182ffc1e973704b7fc95e2e333266cea47940f4abfe663d959e7812813b59218e332abb18c1b23260b2f2a"
    },
    {
      "line": 180,
      "relation": "decreases",
      "evidence": " Animals receiving fasudil had signiﬁcantly lower soluble Aβ1–40 levels than controls (Fig. 4b).",
      "citation": {
        "type": "PubMed",
        "name": "Transl Psychiatry. 2018 Sep 20;8(1):179. doi: 10.1038/s41398-018-0231-6.",
        "reference": "30232325"
      },
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "source": 2,
      "target": 0,
      "key": "9ce5fcabab45b620ea9188edaa146a7d83b84a5ee7c89525ee08d6f8d55738ca37120be81eac1d6d22ed31c46a6615472ff177f2ff0ad772125f61d66c8795d5"
    },
    {
      "relation": "hasComponent",
      "source": 11,
      "target": 2,
      "key": "414b329855fb1b481d41bbebdb979e4a66704b2cad931aa65744727140df04d1dd99b6ea9466bc4f5119d080f65db7708ac4f5a388796b07aa2ad742d0ba0da2"
    },
    {
      "relation": "hasComponent",
      "source": 11,
      "target": 17,
      "key": "98f411c3de8f2b6e2de8c895b4c83d96bede077a3d33ade7d499294cff9a97b6c161cbb2fd4faa4511b06066a185949be1b1c80e910789192a3169f17d0ad87f"
    },
    {
      "line": 164,
      "relation": "causesNoChange",
      "evidence": "Dkk1 resulted in substantial loss of dendritic spines, which was blocked by 10µM fasudil treatment (Fig. 3e, f).",
      "citation": {
        "type": "PubMed",
        "name": "Transl Psychiatry. 2018 Sep 20;8(1):179. doi: 10.1038/s41398-018-0231-6.",
        "reference": "30232325"
      },
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "source": 11,
      "target": 3,
      "key": "0043209bba2127d09eb3361ec660965afdb8bbc6f8661472f3c9b9167cba9221e69f2fd259d7e5794a3464670d5eba6328a5c02a7371046c51f444531930f728"
    },
    {
      "line": 175,
      "relation": "causesNoChange",
      "evidence": "Notably, in parallel with the protective effect of fasudil on synapses (Fig. 3e, f), treatment with fasudil reversed the stimulatory effects of Dkk1 on Aβ production (Fig. 3g).",
      "citation": {
        "type": "PubMed",
        "name": "Transl Psychiatry. 2018 Sep 20;8(1):179. doi: 10.1038/s41398-018-0231-6.",
        "reference": "30232325"
      },
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "source": 11,
      "target": 1,
      "key": "5e889ae30546de4b392442e5954671fe1ed5e389ab905404af43585b5f15674faf8746c536790a3ef86c00b8bc4c6f12e63716c8cab4f375f356e6f05e224c0c"
    }
  ]
}